Andere talen Cytophage Technologies Ltd.

Aandelen

CYTO

CA2328211081

Beurs gesloten - Toronto S.E. Andere beurzen 21:59:05 21-06-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
0,39 ^CAD	0,00%		-11,36%	-44,65%

27/05	Cytophage Technologies Ltd. Versterkt Raad van Bestuur	CI
30/04	Cuspis Capital III Ltd. Rapporteert winstresultaten voor het volledige jaar dat eindigde op 31 december 2023	CI

Andere talen

Krijg toegang tot al het nieuws over alle bedrijven: mis nooit meer een winstgevende beleggingskans!

Gratis inschrijven

Cytophage Expands Commercialization of Phage Products in Asian Poultry Market	20/06
Cytophage CEO to Present at TEDx Winnipeg Event	04/06
Cytophage Reports Q1 Financials and Provides Business Update	30/05
Cytophage Technologies Ltd. Strengthens Board of Directors	27/05
Cytophage Strengthens Board of Directors	27/05
Cytophage Announces Fiscal Year End 2023 Results	30/04
Cuspis Capital III Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Cytophage Technologies Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	30/04
Cytophage Technologies Ltd. Appoints Michael D. Cochrane as Newest Member of Board of Directors	16/04
Cytophage Appoints New Board Director	16/04
Cytophage Technologies Ltd. Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02/04
Cytophage Provides Update on Bacteriophage Human Trial at The Ottawa Hospital	02/04
Cytophage Provides Bacteriophages for Landmark Treatment of Joint Replacement Infection in Canada	01/03
Cytophage Technologies Ltd. Provides Update on Upcoming Product for Egg Production in Canada	12/02
Cytophage Update on Upcoming Product for Egg Production in Canada	12/02
Cytophage Technologies Inc. completed the acquisition of Cuspis Capital III Ltd. (TSXV:CIII.P) in a reverse merger transaction.	02/02
Cuspis Capital III Ltd. Announces Closing of Concurrent Financing by Cytophage Technologies Inc., Receipt of TSXV Conditional Approval, and Certain Loans	23/12
Cuspis Capital III Ltd. announced that it has received CAD 2.5 million in funding	22/12
Cuspis Capital III Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29/11
Cuspis Capital III Ltd. and Cytophage Technologies Inc. Announce Execution of Business Combination Agreement and Concurrent Financing	06/11

Geen resultaten voor deze zoekopdracht

Al het nieuws Aanbevelingen van analisten Belangrijkste gebeurtenissen Insiders Transcripties Persberichten Officiële publicaties Andere talen Ideeën voor de handel MarketScreener-artikels MarketScreener-analyses

Andere talen Cytophage Technologies Ltd.

Aandelen

CYTO

CA2328211081

Andere talen

Filters